Annual report 2023
A unique network with strong partners.
Key figures
Financial key figures
3,746.0
Net sales
in million CHF
191.3
EBIT adjusted
in million CHF
2.20
Dividend
in CHF per share
Key social figures
7,902
Number of employees as of 31.12.2023
5.4
Investment in employee development in million CHF
98.8%
Availability of medicinal products on average 2023
Key environmental figures
46%
Energy consumption from renewable sources
12.0
Energy intensity in MWh/FTE
41%
Waste is recycled on average 2023
Management report
Galenica Group sales performed well in 2023, growing 4.4% to CHF 3,746.0 million. The adjusted EBIT increased slightly to CHF 191.3 million.
Report on non-financial matters pursuant to Art. 964a of the Swiss Code of Obligations
In accordance with the provisions of the Swiss Code of Obligations (CO), we are hereby publishing a report on non-financial matters pursuant to Art. 964a et seq. for the first time for the 2023 financial year.